TMIST Efforts at Marshfield NCORP Site Highlighted
Posted: April 13, 2021
The Marshfield NCORP Community Site’s efforts to encourage women in northcentral Wisconsin to take part in the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) was highlighted recently on local television.
TMIST is the national ongoing study of 2-D vs. 3-D mammography for breast cancer screening to determine whether 3-D is better than 2-D in reducing advanced cancers. In clarifying which women might benefit from a 3-D or 2-D mammogram, the study also will help lead to more personalized guidance about breast cancer screening.
About 230 patients are enrolled through Marshfield Clinic and they will be monitored for at least 8 years. Over 100 community sites nationwide are working to accrue the 100,000 or so participants needed for the study. The video clip can be viewed at: https://www.wsaw.com/2021/04/07/buddy-check-7-trial-compares-2d-and-3d-mammograms/. For more information and a list of participating TMIST sites, see the NCI and ECOG-ACRIN web pages.